Your blog category
The Ministry of Health revealed Friday that demand for Lenacapavir, an HIV prevention injection launched in April, currently surpasses available doses, with more men demanding the twice-yearly drug. Speaking at a meeting attended by HIV advocates, researchers and policymakers, Dr…
Women living with HIV(WLWH) in resource limited settings have benefited greatly from antiretroviral therapy(ART).However, they have several risk factors that can affect their bone health including being female, high parity/breastfeeding, use of life long ART, and HIV disease itself. This…
Science has demonstrated that individuals at high risk of acquiring HIV particularly adolescent girls struggle with daily pill taking and fixed the problem with a twice-yearly injection. As the world marks Women’s Month, The Legacy spotlights Dr. Flavia Matovu Kiweewa, a Makerere…
We are proud to be participating in this year’s CROI conference, currently taking place in Denver Colorado, USA , 22nd- 25th February 2026. Yesterday Dr. Flavia Matovu Kiweewa co-moderated an oral presentation session on, “Beyond the Virus: The Expanding Landscape…
What you need to know Read More >>>
The approval means that data on the drug’s effects have been reviewed and prove that the drug provides benefits that outweigh its known and potential risks for the intended population. The development comes barely six months after the World Health Organisation…
Could new prevention tools eliminate HIV infections? What could end HIV and AIDS as a public health threat? While there is still no vaccine or cure, long-acting tools like Lenacapavir, the twice-yearly HIV prevention shot, could significantly reduce the amount…
Thanks to a landmark deal announced on July 9 by the Global Fund, Uganda is expected to be among the first countries in sub-Saharan Africa to get access to Lenacapavir, a revolutionary new drug that has proven to offer protection…
In an exciting milestone for global health and HIV prevention, Dr. Flavia Matovu Kiweewa has been recognized for her contribution to the development of Lenacapavir, a groundbreaking drug recently approved by the U.S. Food and Drug Administration (FDA) for HIV…
Thanks to two Americans, the best in Medicine and BLIS will receive cash prizes For the next two years, the two best performing students in Makerere University’s Faculty of Medicine and the best Library in Science (BLIS) graduate will receive…
